ICLR - アイコン (ICON plc) アイコン

 ICLRのチャート


 ICLRの企業情報

symbol ICLR
会社名 Icon Plc (アイコン)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Commercial Physical_Biological Resarch  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 アイコン(ICON public limited company)は医薬品開発業務受託機関(CRO)であり、世界的規模で医薬品バイオテクノロジー及び医療機器業界向けに受託開発サービスの提供に従事する。同社はプログラムの戦略的開発、管理および分析に取り組み、化合物選択から、第Ⅰ相試験から第Ⅳ相試験までの臨床試験までを含む全段階の臨床開発プロセスを支援する。ICON中央研究所(ICON Central Laboratories)が提供する特定のサービスはサンプル分析、安全性試験、微生物学、カスタムフローサイトメトリー、テスト結果の電子送信、およびバイオマーカーの開発を含む。平成24年2月28日、同社はPriceSpective LLC (PriceSpective)を買収した。平成24年2月15日、同社はBeijingWits Medical Limited (BeijingWits)を買収した。平成25年2月15日、同社はCross Country Healthcare Inc.の臨床試験サービス事業部を買収した。   アイコンは、アイルランド医薬品開発業務受託会社。医薬品、バイオテクノロジ―、医療機器産業に開発業務受託サ―ビスを提供する。主に、化合物の選択から第I~IV相臨 床試験に至るまでの臨床開発を支援するプログラムの開発、管理、分析を行う。本社は、アイルランドダブリン。   
本社所在地 South County Business Park Leopardstown Dublin 18 IRL
代表者氏名 Ciaran Murray Ciaran Murray
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +353 1-291-2000
設立年月日 1990年
市場名 NASDAQ National Market System
ipoyear 1998年
従業員数 13250人
url www.iconplc.com
nasdaq_url https://www.nasdaq.com/symbol/iclr
adr_tso
EBITDA EBITDA(百万ドル) 427.20200
終値(lastsale) 147.58
時価総額(marketcap) 8017706907.02
時価総額 時価総額(百万ドル) 7724.336
売上高 売上高(百万ドル) 2157.197
企業価値(EV) 企業価値(EV)(百万ドル) 7700.414
当期純利益 当期純利益(百万ドル) 303.42800
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 ICON PLC revenues increased 46% to $1.26B. Net income increased 10% to $150M. Revenues reflect Reimbursable expenses decrease from $306.9M to $0K Revenue increase of 8% to $1.26B. Net income was partially offset by Depreciation and amortization increase of 18% to $33.9M (expense) Restructuring increase of 61% to $12.5M (expense) Interest expense increase of 12% to $7.1M (expense).

 ICLRのテクニカル分析


 ICLRのニュース

   Barclays Stick to Their Hold Rating for Icon plc By Investing.com  2021/04/17 01:10:17 Investing.com
Barclays Stick to Their Hold Rating for Icon plc
   ICON plc to Present at the Barclays Global Healthcare Conference and the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum  2021/03/09 15:00:00 Business Wire
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the Barclays Global Healthcare Conference and the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
   PRA HEALTH SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PRA Health Sciences, Inc. - PRAH  2021/03/02 00:32:00 Business Wire
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of PRA Health Sciences, Inc. (NasdaqGS: PRAH) to -ICON plc, (NasdaqGS: ICLR). Under the terms of the proposed transaction, shareholders of PRA will receive only $80 in cash and 0.4125 shares of ICON stock for each share of PRA that they own. KSF is seeking to determine whether this consideration and the process t
   Icon to Buy Clinical-Trial Rival PRA in $12 Billion Deal  2021/02/24 20:11:00 The Wall Street Journal
Icon PLC’s $12 billion deal to acquire a rival, PRA Health Sciences, would create a contract research powerhouse and expand the role of technology in clinical trials and drug development.
   PRA Health Sciences Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of PRA Health Sciences, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PRAH  2021/02/24 15:48:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of PRA Health Sciences, Inc. (NASDAQ: PRAH) to ICON plc is fair to PRA Health shareholders. Under the terms of the transaction, PRA Health shareholders will receive $80.00 in cash and 0.4125 shares of ICON stock for each PRA Health share that they own. Halper Sadeh encourages PRA Health shareholders to click here to learn more about their legal rights and options or contact Daniel S
   ICON plc to Present at the Barclays Global Healthcare Conference and the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum  2021/03/09 15:00:00 Business Wire
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the Barclays Global Healthcare Conference and the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
   PRA HEALTH SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PRA Health Sciences, Inc. - PRAH  2021/03/02 00:32:00 Business Wire
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of PRA Health Sciences, Inc. (NasdaqGS: PRAH) to -ICON plc, (NasdaqGS: ICLR). Under the terms of the proposed transaction, shareholders of PRA will receive only $80 in cash and 0.4125 shares of ICON stock for each share of PRA that they own. KSF is seeking to determine whether this consideration and the process t
   Icon to Buy Clinical-Trial Rival PRA in $12 Billion Deal  2021/02/24 20:11:00 The Wall Street Journal
Icon PLC’s $12 billion deal to acquire a rival, PRA Health Sciences, would create a contract research powerhouse and expand the role of technology in clinical trials and drug development.
   PRA Health Sciences Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of PRA Health Sciences, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PRAH  2021/02/24 15:48:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of PRA Health Sciences, Inc. (NASDAQ: PRAH) to ICON plc is fair to PRA Health shareholders. Under the terms of the transaction, PRA Health shareholders will receive $80.00 in cash and 0.4125 shares of ICON stock for each PRA Health share that they own. Halper Sadeh encourages PRA Health shareholders to click here to learn more about their legal rights and options or contact Daniel S
   Health Economics and Outcomes Research (HEOR) Services Market With Leading Players like Axtria, Inc. Avalon Health Economics LLC, MEDLIOR PHARMALEX GMBH Analysis Group, ICON PLC, IQVIA, McKESSON CORPORATION Syneos Health Optum  2021/02/24 08:00:00 OpenPR
An off-the-shelf report on Health Economics and Outcomes Research (HEOR) Services Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments
   ICON plc to Present at the Barclays Global Healthcare Conference and the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum  2021/03/09 15:00:00 Business Wire
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the Barclays Global Healthcare Conference and the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
   PRA HEALTH SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PRA Health Sciences, Inc. - PRAH  2021/03/02 00:32:00 Business Wire
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of PRA Health Sciences, Inc. (NasdaqGS: PRAH) to -ICON plc, (NasdaqGS: ICLR). Under the terms of the proposed transaction, shareholders of PRA will receive only $80 in cash and 0.4125 shares of ICON stock for each share of PRA that they own. KSF is seeking to determine whether this consideration and the process t
   Icon to Buy Clinical-Trial Rival PRA in $12 Billion Deal  2021/02/24 20:11:00 The Wall Street Journal
Icon PLC’s $12 billion deal to acquire a rival, PRA Health Sciences, would create a contract research powerhouse and expand the role of technology in clinical trials and drug development.
   PRA Health Sciences Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of PRA Health Sciences, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PRAH  2021/02/24 15:48:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of PRA Health Sciences, Inc. (NASDAQ: PRAH) to ICON plc is fair to PRA Health shareholders. Under the terms of the transaction, PRA Health shareholders will receive $80.00 in cash and 0.4125 shares of ICON stock for each PRA Health share that they own. Halper Sadeh encourages PRA Health shareholders to click here to learn more about their legal rights and options or contact Daniel S
   Health Economics and Outcomes Research (HEOR) Services Market With Leading Players like Axtria, Inc. Avalon Health Economics LLC, MEDLIOR PHARMALEX GMBH Analysis Group, ICON PLC, IQVIA, McKESSON CORPORATION Syneos Health Optum  2021/02/24 08:00:00 OpenPR
An off-the-shelf report on Health Economics and Outcomes Research (HEOR) Services Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 アイコン ICLR ICON plc)

 twitter  (公式ツイッターやCEOツイッターなど)